Recombinant arenin from tree frog D. arenicolor more than doubled glucose uptake in insulin-resistant hepatocytes (52% vs 24%), reduced ROS, and showed concentration-dependent immunomodulation.
2× glucose uptakeArenin more than doubled glucose uptake in insulin-resistant liver cells while simultaneously reducing oxidative stress
What the researchers found
Arenin: glucose uptake increased from 23.97% to 51.38% in IR hepatocytes at 250 μg/mL; time-dependent ROS reduction (lowest 15.78% at 15.62 μg/mL at 24h); concentration-dependent NO immunomodulation in macrophages.
Why it matters
A single peptide addressing insulin resistance, oxidative stress, and immune regulation could simplify treatment of metabolic syndrome.
How the study worked
Heterologous E. coli production of arenin, insulin-resistant HepG2 glucose uptake assays, intracellular ROS measurement at multiple timepoints and concentrations, macrophage NO production analysis.
What this study cannot tell us
In vitro only. High concentrations used. Recombinant production yield and cost not detailed. In vivo efficacy unknown.
How to read the evidence
In vitro proof-of-concept with multiple bioactivity assays. Novel multifunctional peptide needing in vivo validation.
When this study was published
Published in 2025.
The bigger picture
Amphibian skin peptides continue to yield multifunctional bioactives. Arenin's triple activity profile (metabolic + antioxidant + immunomodulatory) is uncommon and therapeutically attractive.
Questions still open
- Would arenin improve metabolic parameters in diabetic animal models?
- Can the insulin-sensitizing mechanism be characterized molecularly?
- Could arenin be developed as a nutraceutical or pharmaceutical?
Common questions
Can a frog peptide treat diabetes?
Why study frog skin peptides?
Read the original research
Insulin Resistance, Anti-inflammatory, and Antioxidant In vitro Activity of Heterologously Expressed Arenin from Dryophytes arenicolor.
Biotechnology reports (Amsterdam, Netherlands), 49, e00947
Citation
Hidalgo-Vázquez, Enrique; Antunes-Ricardo, Marilena; Hernández-Pérez, Jesús; Benavides, Jorge. (2026). Insulin Resistance, Anti-inflammatory, and Antioxidant In vitro Activity of Heterologously Expressed Arenin from Dryophytes arenicolor.. Biotechnology reports (Amsterdam, Netherlands), 49, e00947. https://doi.org/10.1016/j.btre.2026.e00947